Rigel Pharma (RIGL) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $47.28 +0.13%
Revenue Growth %: +15.2%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +15.2%
Financial Fact:
Contract revenues from collaborations: 3.76M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) reported Q1 EPS of ($0.40), $0.04 worse than the analyst estimate of ($0.36).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RH (RH) Tops Q2 EPS by $2.31
- Shoe Station Group Inc. (SHOE) Tops Q2 EPS by 11c ; Offers Guidance
- Academy Sports and Outdoor (ASO) Tops Q2 EPS by 22c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
